Effectiveness of a bivalent mRNA vaccine dose against symptomatic SARS-CoV-2 infection among U.S. Healthcare personnel, September 2022–May 2023
Author:
Plumb Ian D.ORCID, Briggs Hagen Melissa, Wiegand RyanORCID, Dumyati GhinwaORCID, Myers Christopher, Harland Karisa K.ORCID, Krishnadasan Anusha, James Gist Jade, Abedi Glen, Fleming-Dutra Katherine E., Chea Nora, Lee Jane E., Kellogg MelissaORCID, Edmundson Alexandra, Britton Amber, Wilson Lucy E.ORCID, Lovett Sara A.ORCID, Ocampo Valerie, Markus Tiffanie M.ORCID, Smithline Howard A.ORCID, Hou Peter C.ORCID, Lee Lilly C., Mower WilliamORCID, Rwamwejo Fernand, Steele Mark T., Lim Stephen C.ORCID, Schrading Walter A., Chinnock Brian, Beiser David G.ORCID, Faine BrettORCID, Haran John P.ORCID, Nandi Utsav, Chipman Anne K., LoVecchio FrankORCID, Eucker StephanieORCID, Femling Jon, Fuller Matthew, Rothman Richard E., Curlin Marcel E., Talan David A., Mohr Nicholas M.
Subject
Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|